Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 4: Determining the Safe First Human Dose

Speakers

Paul De Koning, MD, PhD, FFPM

Vice President, Head Global Clinical Pharmacology and Exploratory Development, Astellas, United States

Charles Benson, MD, PhD

Senior Director Clinical Phamacology, Eli Lilly and Company, United States

Dr. Benson is a Medical Fellow with Eli Lilly & Co, where he has worked for 13 years. He graduated from M.I.T. before receiving a M.D. Ph.D. from Indiana University. He then trained in Internal Medicine at the Scripps Clinic. He is currently a member of the ICH E14 Implementation Working Group.

Have an account?

Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 4: Determining the Safe First Human Dose

Speakers

Paul De Koning, MD, PhD, FFPM

Charles Benson, MD, PhD

Be informed and stay engaged.